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Abstract—Coronavirus disease 2019 (COVID-19) is a highly
contagious virus spreading all around the world. Deep learning
has been adopted as an effective technique to aid COVID-19
detection and segmentation from computed tomography (CT) im-
ages. The major challenge lies in the inadequate public COVID-
19 datasets. Recently, transfer learning has become a widely
used technique that leverages the knowledge gained while solving
one problem and applying it to a different but related problem.
However, it remains unclear whether various non-COVID19 lung
lesions could contribute to segmenting COVID-19 infection areas
and how to better conduct this transfer procedure. This paper
provides a way to understand the transferability of non-COVID19
lung lesions. Based on a publicly available COVID-19 CT
dataset and three public non-COVID19 datasets, we evaluate four
transfer learning methods using 3D U-Net as a standard encoder-
decoder method. The results reveal the benefits of transferring
knowledge from non-COVID19 lung lesions, and learning from
multiple lung lesion datasets can extract more general features,
leading to accurate and robust pre-trained models. We further
show the capability of the encoder to learn feature representations
of lung lesions, which improves segmentation accuracy and
facilitates training convergence. In addition, our proposed Multi-
encoder learning method incorporates transferred lung lesion
features from non-COVID19 datasets effectively and achieves
significant improvement. These findings promote new insights
into transfer learning for COVID-19 CT image segmentation,
which can also be further generalized to other medical tasks.
Index Terms—COVID-19, CT image, Segmentation, Transfer
learning.
I. INTRODUCTION
IN December 2019, the coronavirus disease 2019 (COVID-19) broke out and has become a global challenge since
then. This new virus was spreading rapidly, affecting countries
worldwide. Up to 13 June 2020, 7,533,177 identified cases
of COVID-19 have been reported in over 216 countries and
territories, resulting in 422,770 deaths. This severe disease has
been declared as a Public Health Emergency of International
Concern by the World Health Organization (WHO).
A gold standard method to screen the COVID-19 pa-
tients is the real-time reverse transcription-polymerase chain
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reaction(rRT-PCR) [1], which requires inconvenient repeated
tests. Researchers found that chest computed tomography (CT)
images show strong ability to capture ground glass and bilat-
eral patchy shadows which are typical CT features in affected
patients [2]. Thus, chest CT can help identify distinguishing
patterns and features in patients. Given that traditional CT
imaging analysis methods are time-consuming and laborious,
it is of great importance to develop artificial intelligence (AI)
systems to aid COVID-19 diagnosis [3].
Segmentation in CT slices is a key component of the
diagnostic work-up for patients with COVID-19 infection in
clinical practice [4]. Recently, deep learning with CNNs has
showed significant performance improvements on the auto-
matic detection and automatic extraction of essential features
from CT images, related to the diagnosis of the Covid-19.
Though deep learning has made great progress in medical
image segmentation, it remains a challenging task in the field
of COVID-19 lung infection, as existing public datasets on
COVID-19 are relatively small and weakly labelled. Thus,
training deep networks from scratch with inadequate data and
task-specific nature such as COVID-19 infection may lead to
over-fitting and poor generalization.
Transfer learning is an effective method to solve this
problem, which helps to leverage knowledge and latent fea-
tures from other datasets and avoids over-parameterization.
In transfer learning, successful deep learning models such as
ResNet, DenseNet and GoogLeNet have been trained on large
datasets such as ImageNet. These pre-trained models have
proven impressive performance on natural image downstream
tasks. However, there exists no large-scale annotated medical
image datasets as data acquisition is difficult, and high-quality
annotations are expensive. Recent research [5] shows that
transfer learning from natural image datasets to medical tasks
produces very limited performance gain. In particular, though
with large medical datasets for pre-training, transfer learning
in the task of COVID-19 infection segmentation is still much
more difficult: 1) The shape, texture and position of COVID-
19 infections are in high variation. 2) Existing large medical
CT datasets differ in domains with COVID-19 datasets. Thus,
similar in domain, a pre-trained model from lung lesions may
share more knowledge with COVID-19 infection and learn
some general-purpose visual representations for lung lesions.
Evidence shows that larger datasets are necessarily better
for pre-training and the diversity of datasets is extremely
important [6]. In medical domain, pre-training from medi-
cal datasets, especially chest CT datasets tends to be more
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2homogeneous compared to non-medical and other medical
areas’ data. Thus, non-COVID19 lung lesion CT imaging
manifestations may serve as potential profit for COVID-19
segmentation. Existing works have proven that multi-task
training through simply fusing different lesions with COVID-
19 affects model’s representation ability for COVID-19 in-
fection segmentation [7]. Therefore, with limited COVID-19
datasets, 1) whether these non-COVID19 lesions help and
to what extent they can contribute to COVID-19 infection
segmentation? 2) How to train a better pre-trained model using
these non-COVID19 datasets for transfer learning? 3) In what
manners can the pre-trained models fitted on non-COVID19
lesions be effectively transferred to COVID-19?
In this paper, we aim to answer the above questions which
are significant for COVID-19 segmentation. To our best knowl-
edge, this is the first study to explore the transferability of non-
COVID19 datasets for COVID-19 CT images segmentation.
Our contributions are as follows.
• We experimentally assess the extent of contributions from
non-COVID19 to COVID-19 infection segmentation. We
found that despite the disparity between non-COVID19
lung lesion images and COVID-19 infection images, pre-
training on the large scale well-annotated lung lesions
may still be transferred to benefit COVID-19 recognition
and segmentation.
• We conduct extensive experiments using various non-
COVID19 lung lesion datasets. Although pre-training
on a single non-COVID19 dataset is unstable among
different transfer strategies, learning from different non-
COVID19 lesions demonstrates promising performance
since such a multi-task learning process can share knowl-
edge from different related tasks and discover common
and general representations of lung lesions.
• We design four different transfer learning strategies
with various performance gains and training time costs:
Continual Learning, Body Fine-tuning, Pre-trained Le-
sion Representations and Multi-encoder Learning. The
Multi-encoder strategy effectively combines both non-
COVID19 and COVID-19 features and shows the best
performance. We further conclude that it is possible to
freeze the encoder and train only the decoder on COVID-
19 tasks during fine-tuning, which provides significant
performance gains and fast convergence speed.
II. RELATED WORKS
In this section, we review the recent related research on
COVID-19 CT images, COVID-19 segmentation and transfer
learning for COVID-19.
A. Research on COVID-19 CT Images.
CT is widely used in the screening and diagnosis of COVID-
19 since ground-glass opacities and bilateral patchy shadows
are the most relative imaging features in pneumonia associated
with infections. Recent research on CT-based diagnosis for
COVID-19 has indicated great performance. Compared with
traditional CT images processing, artificial intelligence (AI)
serves as a core technology, enabling a more accurate and
efficient solution. The machine learning-based CT radiomics
models such as random forest, logistic regression showed
feasibility and accuracy for predicting hospital stay in patients
affected in the work of [8]. Machine learning method was
also adopted by Tang et al. [9] to realize automatic severity
assessment (non-severe or severe) of COVID-19 based on
chest CT images, and to explore the severity-related fea-
tures from the resulting assessment model. Gozes et al. [10]
presented a system that utilized robust 2D and 3D deep
learning models, modifying and adapting existing AI models
and combining them with clinical understanding. Huang et
al. [11] monitored the disease progression and understood the
temporal evolution of COVID-19 quantitatively using serial
CT scan by an automated deep learning method.
B. Research on COVID-19 Segmentation.
Segmentation is an essential step in AI-based image pro-
cessing and analysis [4]. In particular, segmenting the regions
of interests (ROIs) of COVID-19 infections is crucial and
helpful for doctors to make further assessment and quantifica-
tion. However, manual contouring of these infections is time-
consuming and tedious. Although plenty of methods have been
explored on COVID-19 diagnosis and classification, there are
very few works on the segmentation of COVID-19 infection
due to its great annotation challenges.
Shan et al. [12] developed a DL-based system for auto-
matic segmentation and quantification of infection regions and
adopted a human-in-the-loop (HITL) strategy to accelerate the
manual delineation of CT training. Zheng et al. [13] designed
a weakly-supervised deep learning algorithm to investigate
the potential of a deep learning-based model for automatic
COVID-19 detection on chest CT volumes using the weak
patient-level label. Based on semi-supervised learning, Fan et
al. [14] presented a COVID-19 Lung Infection Segmentation
Deep Network (Inf-Net) for CT slices based on randomly
selected propagation. Yan et al. [15] introduced a feature
variation block which adaptively adjusted the global properties
of the features for segmenting COVID-19 infection.
C. Research on COVID-19 Transfer Learning.
In transfer learning, deep models are first trained on large
datasets such as ImageNet, then these pre-trained models are
fine-tuned on different downstream tasks. Several studies [6],
[16], [17] have investigated transfer learning methodologies
on deep neural networks applied to medical image analysis
tasks. Plenty of works used networks pre-trained on natural
images to extract features and followed by another classifier
[18], [19]. Carneiro et al. [19] replaced the fully connected
layers of a pre-trained model with a new logistic layer and
only trained the appended layer, yielding promising results
for classification of unregistered multi-view mammograms.
Other studies performed layer fine-tuning on the pre-trained
networks for adapting the learned features to the target domain.
In [20], CNNs were pre-trained as a feature generator for
chest pathology identification. Gao et al. [21] fine-tuned all
the layers of a pre-trained CNN to classify interstitial lung
3diseases. Ghafoorian et al. [22] trained a CNN on legacy MR
images of brain and evaluated the performance of the domain-
adapted network on the same task with images from a different
domain.
Due to the limited labeled COVID-19 data, several transfer
learning methods have been applied to address this problem.
Chouhan et al. [23] proposed an ensemble approach of transfer
learning using pre-trained models trained on ImageNet. Re-
searchers used five different pre-trained models and analyzed
their performance in chest X-ray images. In the work of [24],
several deep CNNs were employed for automatic COVID-
19 infection detection from X-ray images through tuning
parameters. Majeed et al. [25] presented a critical analysis
for 12 off-the-shelf CNN models and proposed a simple CNN
architecture with a small number of parameters that performed
well on distinguishing COVID-19 from normal X-rays. By
combining three different models which were fine-tuned on 3
datasets, Misra et al. [26] designed a multi-channel ensemble
TL method based on ResNet-18 in such a way that the model
could extract more relevant features for each class and identify
COVID-19 features more accurately from the X-ray images.
Even though the above studies on transfer learning present
inspiring achievement for COVID-19 research, there are sev-
eral limitations: 1) They only focus on the ensemble of existing
CNNs, but ignore the contribution of various datasets for pre-
training. 2) Their studies are limited to X-ray dataset and
only dedicate to COVID-19 detection and classification. 3)
They lack an in-depth study on the transferability of different
transfer manners related to COVID-19 infections. Our work
contributes to a much more difficult task of semantic segmen-
tation in COVID-19 CT images. We explore the transferability
from the perspective of transferring knowledge from various
non-COVID19 lung lesions. Moreover, we investigate better
transfer methods to assist COVID-19 segmentation.
III. METHODOLOGY
In this section, we briefly describe our backbone network,
then introduce the multi-task learning method to get a multi-
lesion pre-trained model. We further give detailed illustration
on four transfer strategies employed in our work.
A. Encoder-Decoder Network
The U-Net is a commonly used network for medical se-
mantic segmentation. As an advanced architecture, it has a U-
shape like structure with an encoding and a decoding signal
path. The encoder serves as a contraction to capture semanti-
cally image contextual features. The decoder is a symmetric
expanding path recovering spatial information. The two paths
are connected using skip connections on each same level,
which recombine with essential high-resolution features from
the encoding path. In this work, we make some minor changes
following nnU-Net [27]. Original batch normalization and
ReLU are replaced by instance normalization and leaky ReLU.
What’s more, deep supervision loss [28] is aggregated to
obtain multi-level deep supervision and facilitate the training
process.
B. Pre-trained Multi-lesion Learning
Multi-task learning is an effective method to share knowl-
edge among different related tasks. As for segmentation tasks,
the performance of each task highly depends on the similarity
among these tasks. Due to the large domain distance among
those existing non-COVID19 lung lesion datasets, fusing these
lesions to train a multi-task segmentation model tends to
underperform on each single task. However, this multi-task
training can exploit the shared knowledge which is essential
for learning some general-purpose visual representations about
lung lesions. Therefore, in our work, besides separately train-
ing segmentation models on each non-COVID19 dataset as
pre-trained models for transfer learning, we provide a multi-
lesion model learning from multiple lung lesions. Compared
with learning from separate tasks, this multi-task strategy leads
to a more robust pre-trained model across all lesion tasks and
empowers downstream COVID-19 task.
C. Continual Learning
Continual Learning aims to learn from an endless stream of
tasks [29]. This paradigm is capable of learning consecutive
tasks without forgetting how to perform previously trained
tasks. This is challenging that the training process tends to
lose knowledge from the previous tasks due to the infor-
mation relevant to current tasks. To avoid this, we adopt a
training schedule to pre-train the model. The value of the
initial learning rate is set as 0.01 and decays throughout
the training process following the poly learning rate policy
(1− epoch / epoch max )0.9. In this way, the learning rate is
decreasing continuously so that the weight parameters after
training non-COVID19 lesion tasks tend to follow its training
process while slightly being updated by the current COVID-19
infection task.
D. Fine-tuning
Fine-tuning is the most standard strategy to transfer
knowledge from domains where data are abundant. In
general, it is conducted by copying the weights from a
pre-trained network and tuning them on the downstream task.
Recent work [30] shows that fine-tuning can enjoy better
performance on small datasets. It is of additional interest to
assess the contribution of the encoder and decoder relative
to learning COVID-19 knowledge. While the progressive
reinitializatons demonstrate the incremental effect of each
layers, it is unnecessary to prob the extent of localized
reinitialization cause our encoder-decoder network is not
very deep. Therefore, we adopt two strategies for tuning a
non-COVID19 lesion model on the COVID-19 downstream
task.
1) Body Fine-tuning: Due to the large domain difference
between pre-trained tasks and downstream tasks, the most
secured fine-tuning method is Body Fine-tuning, which means
all parameters of the pre-trained models are used as the initial
values to complete the training process of the model. When
we train COVID-19 infection networks, all of the parameters
4are assigned initially from the pre-trained models on non-
COVID19 lesions. In this fine-tuning strategy, the update of
parameters largely depends on COVID-19 infection training
process itself. Thus, it is a conservative fine-tuning approach
that the training task of COVID-19 infection is not affected
by the upstream pre-trained non-COVID19 models too much.
2) Pre-trained Lesion Representations: Our segmentation
model is an encoder-decoder architecture and the encoder
serves as a series of convolution operations to encode image
features into context representations. These representations
are trained on large relative datasets from upstream tasks,
and fed as features to downstream ones. In natural language
processing tasks, features extracted from internal representa-
tions of sequence language models are encoded as pre-trained
text representations [29], [30]. In this fine-tuning strategy, we
aim to learn general lung lesion features, which we call Pre-
trained Lesion Representations. We first train models on non-
COVID19 lung lesion datasets. The encoders of these models
are capable of encoding lesion features. In other words, the
encoders’ parameters can exhibit some transferability. Thus,
in the following fine-tuning process on COVID-19 dataset,
we preserve and freeze them while only fine-tuning and re-
training the decoding parts.
E. Multi-encoder Learning
When performing the above fine-tuning strategies, there
exist two problems: 1) Body Fine-tuning easily falls into over-
fitting cause the downstream COVID-19 infection dataset is
much smaller. 2) Utilizing the encoder of pre-trained models
to capture feature representation is unstable, because the label
spaces and losses for the upstream and downstream tasks differ
(Though they are all lung lesions but differ in appearance
and shape). Therefore, we present a new method for transfer
learning. Our method has three key properties:
• It leverages transferred knowledge from other datasets
and combines knowledge from COVID-19 in a better
manner.
• It gains performance improvement in terms of training
from scratch and other transfer learning methods.
• It does not cost more training time.
To achieve these properties, we propose a Multi-encoder archi-
tecture. As shown in Fig.1, this standard U-Net network has
two encoders: self-encoder and adapted-encoder. These two
encoders have the same architecture and share the same de-
coder. Self-encoder is a task-specific feature extractor, focus-
ing on segmenting COVID-19 infection through reinitializing
all the parameters. These parameters are COVID19-specific
which enable update to the network. It is better to assign
initial values from pre-trained models to these parameters for
convergence, which is adopted in our work. The adapted-
encoder is totally frozen while totally using the pre-trained
encoder to capture general lung lesion features. Features from
these two paralleled encoders are concatenated as fusion
of COVID-19 feature representations and then fed into the
decoder part.
Non-COVID19 Lung Lesion 
Decoder
Self-encoder Adapted-encoder
COVID-19 Multi-lesion pre-trained model
MSD tumor StructSeg NSCLC
Fig. 1. An overview of Multi-encoder transfer learning strategy. The U-Net
network consists of a parallel encoder and a shared decoder. Features from
Self-encoder and Adapted-encoder are concatenated.
IV. EXPERIMENTS
In this section, we will describe in detail the datasets,
experimental setup and results of our investigation.
A. Dataset Introduction
1) COVID-19 Dataset: This dataset is released by Coro-
nacases Initiative and Radiopaedia1. It is a publicly available
COVID-19 volume dataset which contains 20 COVID-19 CT
scans. In the work of [7], [31], left lung, right lung, and
infections are well-labelled by two radiologists and verified
by an experienced radiologist. Thus, with over 1800 annotated
slices, this dataset serves as a downstream COVID-19 infection
segmentation dataset for transfer learning in our work.
2) Non-COVID19 Lung Lesion Datasets: In order to better
explore the transferability from various non-COVID19 lung
lesions to COVID-19 infections, the following relationships
need to be satisfied among these datasets: 1) The size of
different lesion datasets are similar. 2) The shape, size and
location of different lesion areas are relatively distinguishing.
Therefore, in this paper, we introduce three public datasets.
MSD Lung Tumor This dataset was used in a crowd-
sourced challenge of generalized semantic segmentation al-
gorithms called the Medical Segmentation Decathlon (MSD)
held in MICCAI 20182. This dataset includes patients with
non-small cell lung cancer from Stanford University (Palo
Alto, CA, USA) publicly available through TCIA and pre-
viously utilized to create a radiogenomic signature [32], [33],
[34]. The tumor regions are denoted by an expert thoracic
radiologist on a representative CT cross section using OsiriX
[35]. 63 3D CT scans with corresponding tumor segmentation
masks are utilized in our paper.
StructSeg Lung Cancer StructSeg organ dataset is a
collection of 3D organ CT scans along with their segmentation
ground-truth from 2019 MICCAI challenge3. This dataset
contains two types of cancers, nasopharyngeal cancer and lung
1https://github.com/ieee8023/covid-chestxray-dataset
2http://medicaldecathlon.com/
3https://structseg2019.grand-challenge.org
5cancer. We adopt the gross target volume segmentation of lung
cancer from 50 patients. Each CT scan is annotated by an
experienced oncologist and verified by another one.
NSCLC Pleural Effusion This dataset is developed from
a Non-Small Cell Lung Cancer (NSCLC) cohort of 211
subjects4. 78 cases with pleural effusion are selected with their
segmentation masks.
B. Experimental Settings
All the experiments are implemented in Pytorch and trained
on NVIDIA Tesla V100 32GB GPU. For fair comparison, we
follow the settings on COVID-19 dataset benchmarks in [7].
For the COVID-19 dataset, we use 5-fold cross validation
based on a pre-defined dataset split file. Each fold contains 4
scans (20%) for training and 16 (80%) for testing.
For non-COVID19 lung lesion datasets, we all randomly
select 80% of the data for training and the rest of 20% for
validation. Pre-trained models based on these non-COVID19
lesions are all trained from scratch with random initial pa-
rameters using 3D U-Net network. Due to the limited number
of different lesion cases, we do data pre-processing following
nnU-Net [27]. The input patch size is set as 50×160×192
and batch size as 2. Stochastic gradient descent optimizer
with an initial learning rate of 0.01 and a nesterov momentum
of 0.99 are used for non-COVID19 pre-training. We adopt
a summation of Dice loss and Cross entropy loss as loss
function.
C. Evaluation Metrics
Diagnostic evaluation is often used in clinical practice for
disease diagnosis, patient follow-up or efficacy monitoring.
Whether the results of a certain diagnostic evaluation are
true, reliable and practical, will largely determine a reasonable
medical decision. In this work, we introduce five evaluation
metrics for the exploration of transferability.
Dice similarity coefficient (DSC) measures volumetric over-
lap between segmentation results and annotations. It is com-
puted by:
DSC(A,B) =
2|A ∩B|
|A|+ |B| , (1)
where A is the sets of foreground voxels in the annotation
and B is the corresponding sets of foreground voxels in the
segmentation result, respectively.
Normalized surface distance (NSD) [36] serves as a
distance-based measurement to assess performance. It is com-
puted by:
NSD(A,B) =
∣∣∣∂A ∩R(τ)∂B∣∣∣ + ∣∣∣∂B ∩R(τ)∂A∣∣∣
|∂A|+ |∂B| , (2)
where R(τ)∂A and R
(τ)
∂B represent the borders of ground-truth and
segmentation masks which use a threshold τ to tolerate the
inter-rater variability of the annotators. We set τ = 3mm for
COVID-19 infection. In contrast to the DSC, which measures
4https://wiki.cancerimagingarchive.net/display/Public/NSCLC-Radiomics
the overlap of volumes, the NSD measures the overlap of two
surfaces.
We also consider three other evaluation metrics. Accuracy
denotes the correct rate for both positive and negative predic-
tions. Sensitivity shows the percentage of positive instances
correctly identified positive. F1-score is the weighted harmonic
average of Precision and Sensitivity which is an effective and
comprehensive evaluation.
D. Analysis of Different Non-COVID19 Pre-trained Models
All of the four pre-trained models (MSD, StructSeg,
NSCLC, Multi-lesion) are utilized to investigate the ability
of transfer learning to COVID-19 datasets. With extensive
experiments in Table I, we observe that different pre-trained
models show different transferability. The best scores of
models corresponding to each transfer learning strategies are
highlighted along with the detailed comparative analysis of 5
validation folds.
1) Single-lesion Pre-trained Model: Among pre-trained
models on each single lesion (MSD, StructSeg, NSCLC),
compared with training COVID-19 datasets from scratch,
MSD tumor pre-trained model improves the segmentation by
3.0% DSC and 3.2% NSD at most. Meanwhile, StructSeg and
NSCLC lung lesion pre-trained models show instability under
different transfer strategies. As shown in Table I, with Contin-
ual Learning and Body Fine-tuning strategies, StructSeg and
NSCLC pre-trained models can achieve promising improve-
ment in most folds, but instead, they obtain lower performance
with the strategy of Pre-trained Lesion Representations. The
rationale is that there exists a large domain distance between
these two lesions and COVID-19 infection. The strategy
of Pre-trained Lesion Representations totally uses encoded
non-COVID19 lesion features. Thus, the transferability of a
single-lesion dataset model largely depends on their domain
difference.
2) Multi-lesion Pre-trained Model: As shown in Table I, we
further notice that among all transfer learning strategies, multi-
lesion pre-trained model not only achieves a high percentage
for DSC and NSD values, but also performs the most stably
among all pre-trained models, with the average DSC value
of 0.696, 0.696, 0.693, 0.703, respectively. This shows the
robustness of a multi-lesion pre-trained model used for transfer
learning to COVID-19 infection. Table II further verifies
this demonstration using Sensitivity, F1-score and Accuracy
concerned with different transfer strategies. It is observed that
transferring from multi-lesion pre-trained model outperforms
training from scratch on all these evaluation metrics among all
strategies. Significantly, when it comes to Pre-trained Lesion
Representations, where the encoder of pre-trained models is
totally frozen and serves as a non-COVID19 lesion features
extractor, the multi-lesion pre-trained model can still perform
well. This confirms the effectiveness of multi-task training
for multiple lung lesions, which generates more robust and
general-purpose representations to help COVID-19 infection
tasks. Fig.2(a)-(e) show some examples of segmentation re-
sults of the above pre-trained models. It is clear that compared
with training from scratch, pre-training from single non-
COVID19 models can obtain more accurate massive structures
6CT Image Train from scratchGround-truth MSD StructSeg NSCLC Multi-lesion
( a )
( b )
( c )
( d )
( e )
Fig. 2. Visual comparison of COVID-19 infection segmentation results. Training from scratch means using no pre-trained models. MSD, StructSeg, NSCLC
and Multi-lesion mean using pre-trained models from corresponding non-COVID19 lesion datasets.
TABLE I
RESULTS OF 5-FOLD CROSS VALIDATION OF DIFFERENT TRANSFER LEARNING STRATEGIES UNDER DIFFERENT NON-COVID19 LUNG LESION
PRE-TRAINED MODELS. THE BEST RESULTS ARE SHOWN IN RED FONT.
Transfer Strategy
Pre-trained
model
fold 0 fold 1 fold 2 fold 3 fold 4 AVG
DSC NSD DSC NSD DSC NSD DSC NSD DSC NSD DSC NSD
Train from
scratch
None 0.681±0.205 0.709±0.213 0.713±0.205 0.718±0.230 0.662±0.217 0.717±0.242 0.681±0.231 0.708±0.271 0.627±0.269 0.649±0.282 0.673±0.223 0.700±0.224
Continual
Learning
MSD 0.696±0.211 0.725±0.219 0.731±0.206 0.734±0.238 0.724±0.166 0.782±0.180 0.720±0.205 0.745±0.224 0.646±0.235 0.672±0.242 0.703±0.203 0.732±0.219
StructSeg 0.672±0.234 0.704±0.231 0.712±0.206 0.716±0.234 0.704±0.163 0.762±0.183 0.717±0.192 0.745±0.208 0.600±0.264 0.616±0.276 0.681±0.214 0.709±0.228
NSCLC 0.673±0.215 0.702±0.219 0.712±0.209 0.720±0.244 0.722±0.145 0.775±0.169 0.720±0.209 0.745±0.235 0.581±0.283 0.605±0.292 0.681±0.218 0.709±0.237
Multi-lesion 0.709±0.209 0.726±0.220 0.740±0.209 0.735±0.232 0.692±0.191 0.745±0.198 0.721±0.208 0.749±0.219 0.618±0.251 0.638±0.260 0.696±0.213 0.718±0.225
Body
Fine-tuning
MSD 0.679±0.214 0.706±0.224 0.706±0.210 0.708±0.250 0.724±0.157 0.785±0.167 0.708±0.178 0.724±0.228 0.623±0.247 0.642±0.253 0.688±0.201 0.713±0.225
StructSeg 0.689±0.203 0.710±0.222 0.719±0.207 0.721±0.238 0.713±0.161 0.770±0.173 0.724±0.209 0.743±0.231 0.603±0.265 0.617±0.271 0.689±0.211 0.712±0.229
NSCLC 0.696±0.197 0.714±0.213 0.716±0.206 0.720±0.239 0.673±0.208 0.734±0.219 0.690±0.229 0.707±0.266 0.579±0.288 0.590±0.298 0.671±0.228 0.693±0.248
Multi-lesion 0.702±0.209 0.715±0.221 0.736±0.209 0.730±0.235 0.703±0.182 0.755±0.188 0.725±0.211 0.754±0.225 0.612±0.254 0.628±0.263 0.696±0.213 0.717±0.227
Pre-trained
Lesion
Representations
MSD 0.709±0.210 0.735±0.225 0.741±0.207 0.751±0.233 0.713±0.159 0.763±0.173 0.693±0.217 0.689±0.262 0.618±0.249 0.637±0.258 0.695±0.209 0.715±0.232
StructSeg 0.657±0.231 0.670±0.243 0.696±0.215 0.687±0.249 0.657±0.233 0.701±0.246 0.682±0.231 0.701±0.237 0.536±0.271 0.535±0.276 0.645±0.238 0.659±0.252
NSCLC 0.663±0.214 0.668±0.224 0.695±0.209 0.683±0.241 0.626±0.240 0.664±0.251 0.658±0.229 0.670±0.254 0.544±0.285 0.543±0.294 0.637±0.237 0.646±0.253
Multi-lesion 0.704±0.210 0.728±0.220 0.731±0.208 0.737±0.235 0.705±0.193 0.748±0.213 0.725±0.209 0.751±0.221 0.602±0.265 0.618±0.271 0.693±0.218 0.716±0.232
Multi-encoder Multi-lesion 0.712±0.210 0.735±0.223 0.732±0.208 0.740±0.235 0.721±0.148 0.785±0.159 0.742±0.112 0.772±0.145 0.608±0.278 0.629±0.286 0.703±0.201 0.732±0.218
of COVID-19 but shows dissatisfying instability. However,
pre-training from multi-lesion model shows high precision and
smooth boundary like manually annotated.
E. Analysis of Different Transfer Learning Strategies
Based on the above conclusion that multi-lesion pre-trained
model brings consistently higher accuracy and robustness, we
further analyze the performance of different transfer strategies
adopted in this paper.
Table III shows the results of COVID-19 infection segmen-
tation using the same multi-lesion pre-trained model under
different transfer strategies. These results suggest that all the
transfer strategies improve the performance of training from
scratch on average DSC, NSD and Sensitivity. In particular,
in fold 3, they improve the segmentation by more than 6.0%
DSC and 6.4% NSD on maximum. The strategies of Continual
Learning and Body Fine-tuning get similar promising results,
which both improve the segmentation by 2.3% DSC, 1.8%
NSD and 3.4% Sensitivity on average.
An interesting observation is that, compared with Continual
Learning and Body Fine-tuning, where all the parameters are
updated on COVID-19 dataset, the strategy of Pre-trained Le-
sion Representations still achieves a competitive performance
with an entirely frozen encoder and inherited weights of pre-
trained non-COVID19 models. It is observed to improve the
DSC from 0.673 to 0.693, NSD from 0.700 to 0.716 and
7Multi-encoder
Train from scratch
Ground-truth
CT Image
( a ) ( b ) ( c ) ( d ) ( e ) ( f )
Fig. 3. Visual comparison of COVID-19 infection segmentation results between training from scratch and proposed Multi-encoder transfer learning strategy
based on multi-lesion pre-trained model.
TABLE II
RESULTS OF AVERAGE SENSITIVITY, F1-SCORE AND ACCURACY OF
DIFFERENT TRANSFER LEARNING STRATEGIES UNDER DIFFERENT
NON-COVID19 LUNG LESION PRE-TRIANED MODELS. THE BEST RESULTS
ARE SHOWN IN RED FONT.
Sensitivity F1-score Accuracy
Train from
scratch
0.6204±0.2369 0.6728±0.2227 0.9939±0.0086
Continual Learning
MSD 0.6592±0.2148 0.7033±0.2029 0.9942±0.0083
StructSeg 0.6317±0.2224 0.6809±0.2139 0.9941±0.0081
NSCLC 0.6371±0.2249 0.6814±0.2180 0.9939±0.0086
Multi-lesion 0.6545±0.2244 0.6962±0.2134 0.9941±0.0083
Body Fine-tuning
MSD 0.6482±0.2186 0.6877±0.2170 0.9934±0.0100
StructSeg 0.6392±0.2312 0.6894±0.2112 0.9940±0.0083
NSCLC 0.6270±0.2041 0.6709±0.2277 0.9941±0.0086
Multi-lesion 0.6528±0.2252 0.6956±0.1328 0.9941±0.0083
Pre-trained Lesion Representations
MSD 0.6809±0.2055 0.6949±0.2093 0.9940±0.0083
StructSeg 0.6218±0.2362 0.6455±0.2382 0.9926±0.0118
NSCLC 0.6200±0.2376 0.6371±0.2368 0.9929±0.0096
Multi-lesion 0.6622±0.2117 0.6934±0.2185 0.9940±0.0082
Multi-encoder
Multi-lesion 0.6635±0.2076 0.7035±0.1995 0.9942±0.0079
Sensitivity from 0.643 to 0.662. In particular, in terms of
training cost, Table III shows the training time (per epoch) for
each transfer strategy. It can be clearly seen that the strategy of
Pre-trained Lesion Representations spends just 148s per epoch
on average, much less than training from scratch and other
transfer strategies. Due to the frozen encoder, the strategy of
Pre-trained Lesion Representations cuts down nearly a half
of parameters that need to be updated. Thus, it is promising
to adopt this strategy for COVID-19 transfer learning to save
training costs and gain fast convergence.
It is also observed in Table III that our proposed Multi-
encoder transfer learning strategy exhibits significantly better
segmentation performance than other strategies using multi-
lesion pre-trained model. It improves the average DSC from
0.673 to 0.703 and NSD from 0.700 to 0.732, which also
performs best among all the pre-trained models in Table I.
In terms of F1-score and Accuracy in Table II, proposed
Multi-encoder learning outperforms other strategies and en-
hances the values to 0.7035 and 0.9942, respectively. The
transfer ability of Multi-encoder is also confirmed by Fig.3.
Compared with training from scratch, Multi-encoder learning
yields segmentation results with more accurate boundaries in
Fig.3(b)(c)(e) and identifies some minor COVID-19 infection
areas in Fig.3(a)(d)(f). The success of proposed Multi-encoder
learning strategy is owed to the designed parallel encoders,
where the COVID-19 and non-COVID19 lesions are both
employed for encoding feature representations, leading to
better generalization and lower over-fitting risks.
V. DISCUSSION AND CONCLUSION
In this paper, we investigate the transferability in COVID-
19 CT segmentation. We present a set of experiments to better
understand how different non-COVID19 lung lesions influence
the performance of COVID-19 infection segmentation and
their different transfer ability under different transfer learning
strategies. Our results reveal clear benefits of pre-training on
non-COVID19 datasets.
A valuable demonstration is that a multi-lesion pre-trained
model can make the best of multiple lesion representations,
and advance the generalization and robustness of pre-trained
models. There is value in recognizing that the CT appearance
of these different lung lesions share some similarity. Thus, with
more kinds of lung lesion datasets incorporated to pre-train a
8TABLE III
RESULTS OF 5-FOLD CROSS VALIDATION OF DIFFERENT TRANSFER LEARNING STRATEGIES BASED ON MULTI-LESION PRE-TRAINED MODEL. TIME
REPRESENTS THE TRAINING TIME FOR AN EPOCH. THE BEST RESULTS ARE SHOWN IN RED FONT.
Train from scratch Continual Learning Body Fine-tuning Lesion Representations Multi-encoder
DSC↑ NSD↑ Sen.↑ Time↓ DSC↑ NSD↑ Sen.↑ Time↓ DSC↑ NSD↑ Sen.↑ Time↓ DSC↑ NSD↑ Sen.↑ Time↓ DSC↑ NSD↑ Sen.↑ Time↓
fold 0
avg 0.681 0.709 0.639 224s 0.709 0.726 0.683 194s 0.702 0.715 0.668 196s 0.704 0.728 0.682 145s 0.712 0.735 0.693 206s
std 0.205 0.213 0.162 – 0.209 0.220 0.161 – 0.209 0.221 0.160 – 0.210 0.220 0.156 – 0.210 0.223 0.151 –
fold 1
avg 0.713 0.718 0.707 194s 0.740 0.735 0.752 193s 0.736 0.730 0.754 196s 0.731 0.737 0.762 145s 0.732 0.740 0.769 201s
std 0.205 0.230 0.189 – 0.209 0.232 0.204 – 0.209 0.235 0.172 – 0.208 0.235 0.126 – 0.208 0.235 0.129 –
fold 2
avg 0.662 0.717 0.621 224s 0.692 0.745 0.667 193s 0.703 0.755 0.688 194s 0.705 0.748 0.676 146s 0.721 0.785 0.685 208s
std 0.217 0.242 0.295 – 0.191 0.198 0.272 – 0.182 0.188 0.262 – 0.193 0.213 0.260 – 0.148 0.159 0.232 –
fold 3
avg 0.681 0.708 0.604 194s 0.721 0.749 0.657 193s 0.725 0.754 0.648 196s 0.725 0.751 0.696 148s 0.742 0.772 0.659 208s
std 0.231 0.271 0.241 – 0.208 0.219 0.164 – 0.211 0.225 0.203 – 0.209 0.221 0.143 – 0.112 0.145 0.152 –
fold 4
avg 0.627 0.649 0.531 194s 0.618 0.638 0.514 223s 0.612 0.628 0.506 194s 0.602 0.618 0.495 157s 0.608 0.629 0.512 208s
std 0.269 0.282 0.267 – 0.251 0.260 0.254 – 0.254 0.263 0.258 196s 0.265 0.271 0.255 – 0.278 0.286 0.270 –
AVG
avg 0.673 0.700 0.620 206s 0.696 0.718 0.655 199s 0.696 0.717 0.653 195s 0.693 0.716 0.662 148s 0.703 0.732 0.663 206s
std 0.223 0.224 0.237 16s 0.213 0.225 0.224 13s 0.213 0.227 0.225 1s 0.218 0.232 0.212 5s 0.201 0.218 0.208 3s
model, we could achieve better performance. This exploration
is an important contribution, enabling more research on trans-
fer learning to COVID-19 infection from the perspective of
utilizing non-COVID19 lung lesions.
Moreover, this paper examines a series of different transfer
learning strategies, including Continual Learning, Body Fine-
tuning, Pre-trained Lesion Representations and the proposed
Multi-encoder Learning. We observe segmentation improve-
ment in all performance metrics. It is also noted that the
strategy of Pre-trained Lesion Representations with a frozen
encoder enhances performance as well. This gains more
insight into the significant transferability exhibited by the
encoding parameters. Though the encoding layers do not
contain any explicit knowledge of the COVID-19 infection,
their parameters still enable the optimizer to reach a higher
performance while fine-tuning. The rationale is that the en-
coded multi-lesion representations contain more high-level
and abundant encoding information of the medically relevant
lung lesion observed in CT images. Through combining the
multi-lesion representations and COVID-19 infection features,
the proposed Multi-encoder achieves significant improvement.
These observation and exploration are important not only in
COVID-19 transfer learning but also in the general medical
domain, because feature reuse from pre-training out-of-domain
datasets shows significant improvement for task performance
and training convergence.
Future research directions include utilizing more various
non-COVID19 lung lesion datasets and investigating better
transfer learning methods, so that non-COVID19 lung lesions
can be effectively used to improve the quality of COVID-19
infection segmentation in the absence of sufficient high-quality
COVID-19 datasets.
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